Document is current
Any future updates will be listed below
-
Authors
Alberti, Paola https://orcid.org/0000-0001-6106-6183
Rossi, Emanuela
Argyriou, Andreas A.
Kalofonos, Haralabos P.
Briani, Chiara
Cacciavillani, Mario
Campagnolo, Marta
Bruna, Jordi
Velasco, Roser
Cazzaniga, Marina E.
Cortinovis, Diego
Valsecchi, Maria G.
Cavaletti, Guido
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG2016-18631)
- License Information
-
More Information
Article History
Received: 19 July 2017
Accepted: 19 March 2018
First Online: 29 March 2018
Compliance with ethical standards
: The study had obtained approval from the ethics review board of each participating center [IRB number approval for each center: 12474/14.05.2008 (Patras, Greece), 215/06 (Barcelona, Spain), 1999P/18.01.2010 (Padua, Italy), 442/29.07.2010 (Monza, Italy)], and the participants provided written informed consent.
: GC is an expert advisory board member to design a neuroprotection clinical trial for PledPharma and is a recipient of AIRC grant IG2016-18631 (competitive research grant to investigate on chemotherapy-induced peripheral neurotoxicity and strategies to reduce its severity). The other authors have nothing to disclose. The authors have full control of primary data.
